Asunto(s)
COVID-19 , Estrés Laboral/etiología , Médicos/psicología , Adaptación Psicológica , Adulto , Anciano , Agotamiento Profesional , Femenino , Humanos , Masculino , Persona de Mediana Edad , Moral , Personal de Enfermería en Hospital/psicología , Pandemias , Equipo de Protección Personal , Relaciones Médico-Paciente , Relaciones Profesional-Familia , Encuestas y Cuestionarios , Telemedicina , Visitas a PacientesRESUMEN
Coronavirus disease 2019 (COVID-19) is an infection caused by the severe acute respiratory syndrome-coronavirus-2 virus that led to a pandemic. Acute manifestations of COVID-19 include fever, cough, dyspnea, respiratory failure, pneumonitis, anosmia, thromboembolic events, cardiogenic shock, renal injury, ischemic strokes, encephalitis, and cutaneous eruptions, especially of hands or feet. Prolonged symptoms, unpredictable recoveries, and chronic sequelae (long COVID) sometimes emerge even for some people who survive the initial illness. Sequelae such as fatigue occasionally persist even for those with only mild to moderate cases. There is much to learn about postacute COVID-19 dyspnea, anosmia, psychosis, thyroiditis, cardiac arrhythmia, and/or multisystem inflammatory response syndrome in children. Determining prognoses is imprecise. Examining patient databases about those who have survived COVID-19 is warranted. Multidisciplinary teams are assessing such disease databases to better understand longer-term complications and guide treatment.
Asunto(s)
COVID-19/complicaciones , COVID-19/epidemiología , Comorbilidad , Humanos , Incidencia , Pandemias , Pronóstico , SARS-CoV-2 , Síndrome Post Agudo de COVID-19Asunto(s)
Antidepresivos/efectos adversos , Arritmias Cardíacas/inducido químicamente , Tratamiento Farmacológico de COVID-19 , Trastorno Depresivo/tratamiento farmacológico , Cardiopatías/fisiopatología , Antivirales/efectos adversos , Arritmias Cardíacas/etiología , Fibrilación Atrial/fisiopatología , Bloqueo Atrioventricular/inducido químicamente , Bloqueo de Rama/inducido químicamente , COVID-19/fisiopatología , Cloroquina/efectos adversos , Trastorno Depresivo/fisiopatología , Humanos , Hidroxicloroquina/efectos adversos , Síndrome de QT Prolongado/inducido químicamente , Torsades de Pointes/inducido químicamenteAsunto(s)
Infecciones por Coronavirus , Transmisión de Enfermedad Infecciosa/prevención & control , Trastornos Mentales , Pandemias , Neumonía Viral , Betacoronavirus/aislamiento & purificación , COVID-19 , Control de Enfermedades Transmisibles/métodos , Comorbilidad , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/psicología , Infecciones por Coronavirus/terapia , Humanos , Trastornos Mentales/diagnóstico , Trastornos Mentales/epidemiología , Neumonía Viral/epidemiología , Neumonía Viral/psicología , Neumonía Viral/terapia , SARS-CoV-2 , Aislamiento Social/psicología , Apoyo SocialRESUMEN
The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) causes the coronavirus disease 2019 (COVID-19). It quickly became pandemic, and so did a new concern about COVID-19 infections increasing the risk for cerebrovascular diseases. There is an association between COVID-19 illness in people and acute stroke. Several chemical, mechanical, and/or inflammatory central nervous system pathologies are proposed to explain how this viral infection might induce acute cerebrovascular disease. Timely available evaluation and/or intervention is imperative for patients with concerns about acute cerebrovascular issues.